American WellNYSE: AMWL

Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock (collectively, the “Common Stock”), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company's Class A common stock are expected to begin trading on the New York Stock Exchange (“NYSE”) on a split-adjusted basis at the market open on July 11, 2024. No change will be made to the trading symbol for the Company's shares of Class A common stock, “AMWL”, in connection with the Reverse Split.

Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13.

American Well Corporation held its Q1 2024 Earnings Call on May 1, 2024, with various company representatives and analysts participating in the conference call. The conference operator for the call was Briana.

While the revenue and EPS of American Well (AMWL) provide an indication of its performance in the quarter ending March 2024, it is important to also evaluate how certain important metrics stack up against analyst forecasts and figures from the same period last year.

American Well Corporation (AMWL) reported a quarterly loss of $0.25 per share, which was higher than the expected loss of $0.18 per share according to the Zacks Consensus Estimate. This is compared to a loss of $0.24 per share in the same quarter last year.

The headline numbers for American Well Corporation (AMWL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Amwell announced better-than-expected fourth-quarter results. The telemedicine platform provider also issued strong preliminary 2025 guidance.

American Well Corporation (AMWL) Q4 2023 Earnings Call Transcript

American Well Corporation (AMWL) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.22 per share a year ago.